Posts by Admin BioAlps

A partnership of medtech pioneers and company-builders   Distalmotion, based in Lausanne (Switzerland), Revival Healthcare Capital and 415 CAPITAL announced the closing of a USD 90 million Series E financing round to accelerate the adoption of Distalmotion’s surgical robot Dexter. The investment follows Dexter’s successful initial clinical use and supports Distalmotion’s international commercial scaling.  …

The pharmaceutical group Takeda wishes to increase the production capacity of its site in Neuchâtel (Switzerland) and will build a new building estimated at CHF 30 million.   More information

Development & commercialisation of ZYNLONTA in Japan   ADC Therapeutics SA, a commercial-stage biotechnology company improving the lives of those affected by cancer with its next-generation, targeted antibody drug conjugates (ADCs) for patients with hematologic malignancies and solid tumors, announced it has entered an exclusive license agreement with Mitsubishi Tanabe Pharma Corporation (MTPC) for the…

Development of national secure platforms, leading open science databases & software tools    The Swiss Institute of Bioinformatics (SIB)’s mission, as per its mandate from the Secretariat for Education, Research and Innovation (SERI), is to be a provider of long-term, high-impact infrastructure for the life sciences and the biomedical world. Its teams thus develop national…

Multiplex miCAR™ Technology   Allogene Therapeutics, a clinical-stage biotechnology company pioneering the development of allogeneic CAR T (AlloCAR T™) products for cancer and Antion Biosciences, a Swiss cell and gene engineering company, announced that they have entered into an exclusive collaboration and global license agreement for Antion’s miRNA technology (miCAR™) to advance multiplex gene silencing…

CHF 1.8M to start clinical trials & product industrialisation   Adiposs SA, the developer of a unique diagnostic product for the non-invasive early detection of body wasting-cachexia, announced a CHF 1.8M first closing of its Pre-Series A round. The round was led by Privilège Ventures, a Swiss-based venture capital firm focused on seed and early-stage…

89 new innovative projects in 2022   Venture Kick continues its success story and increases its budget: having supported 841 spin-offs from Swiss universities with CHF 39.71 million in seed capital since 2007, Venture Kick increases the 2022 budget by 10% to CHF 6.1 million. This will allow Venture Kick to provide funds to 89…

Magali Bischof promoted Secretary General of the BioAlps Association   The Executive Committee of the BioAlps Association has chosen Mrs Magali Bischof as the next Secretary General. She will take up her position on 1 January 2022.   BioAlps is celebrating its 20th anniversary supporting Life Sciences innovation in Western Switzerland. The Association builds bridges…

1st closing new financing round with Swiss & international investors   Xsensio, a Lausanne based startup seeking to address the emerging field of wearable biosensing, has successfully completed a first close of its new financing round with Swiss and international investors to address the fast-growing market of wearable biosensing. Xsensio develops the unique Lab-on-Skin sensing…